Efficacy and safety of rasagiline monotherapy in Japanese patients with early Parkinson’s disease: A phase 3, randomized, double-blind, placebo-controlled, multicenter study

Journal of the Neurological Sciences ◽

10.1016/j.jns.2017.08.662 ◽

2017 ◽

Vol 381 ◽

pp. 231-232 ◽

Cited By ~ 1

Author(s):

N. Hattori ◽

A. Takeda ◽

S. Takeda ◽

A. Nishimura ◽

T. Kitagawa ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Multicenter Study ◽

Japanese Patients ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Early Parkinson’S Disease

Download Full-text

Efficacy and safety of istradefylline in moderate to severe Parkinson’s disease: A phase 3, multinational, randomized, double-blind, placebo-controlled trial (i-step study)

Journal of the Neurological Sciences ◽

10.1016/j.jns.2017.08.999 ◽

2017 ◽

Vol 381 ◽

pp. 351-352 ◽

Cited By ~ 1

Author(s):

S. Isaacson ◽

K. Eggert ◽

R. Kumar ◽

F. Stocchi ◽

A. Mori ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Step Study

Download Full-text

Efficacy and safety of adjunctive rasagiline in Japanese Parkinson's disease patients with wearing-off phenomena: A phase 2/3, randomized, double-blind, placebo-controlled, multicenter study

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2018.04.025 ◽

2018 ◽

Vol 53 ◽

pp. 21-27 ◽

Cited By ~ 4

Author(s):

Nobutaka Hattori ◽

Atsushi Takeda ◽

Shinichi Takeda ◽

Akira Nishimura ◽

Masafumi Kato ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Multicenter Study ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Wearing Off

Download Full-text

Faculty Opinions recommendation of Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737065221.793569342 ◽

2020 ◽

Author(s):

Joseph Jankovic ◽

Arjun Tarakad

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of foslevodopa/foscarbidopa versus oral carbidopa/levodopa in advanced Parkinson's disease patients: Design of a phase 3, randomized, double-blind, double-dummy, active controlled 12-week trial

Journal of the Neurological Sciences ◽

10.1016/j.jns.2021.119569 ◽

2021 ◽

Vol 429 ◽

pp. 119569

Author(s):

Maurizio Facheris ◽

Weining Robieson ◽

Nahome Fisseha ◽

David Standaert

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Advanced Parkinson’S Disease

Download Full-text

Corrigendum to “Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study” [Park. Relat. Disord. 28 (2016) 49–55]

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2017.02.030 ◽

2017 ◽

Vol 38 ◽

pp. 108

Author(s):

Zhen-Xin Zhang ◽

Hui-Fang Shang ◽

Xingyue Hu ◽

Shengdi Chen ◽

Zhongxin Zhao ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Chinese Patients ◽

Transdermal Patch ◽

Double Blind ◽

Double Blind Placebo ◽

Pivotal Study ◽

Rotigotine Transdermal Patch ◽

Early Parkinson’S Disease

Download Full-text

A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients

Movement Disorders ◽

10.1002/mds.23954 ◽

2011 ◽

Vol 27 (1) ◽

pp. 106-112 ◽

Cited By ~ 66

Author(s):

Fabrizio Stocchi ◽

Rupam Borgohain ◽

Marco Onofrj ◽

Anthony H.V. Schapira ◽

Mohit Bhatt ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Early Parkinson’S Disease

Download Full-text

The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study

Movement Disorders ◽

10.1002/mds.26235 ◽

2015 ◽

Vol 30 (7) ◽

pp. 1009-1009

Author(s):

Hasmet A. Hanagasi

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Cognitive Deficits ◽

Multicenter Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

P-288 Global Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Compare Efficacy and Safety of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Plus nab-Paclitaxel and Gemcitabine vs. Placebo Plus nab-Paclitaxel and Gemcitabine

Annals of Oncology ◽

10.1093/annonc/mdw199.278 ◽

2016 ◽

Vol 27 ◽

pp. ii84

Author(s):

Tempero Margaret ◽

Hingorani Sunil ◽

Zheng Lei ◽

Reni Michele ◽

Hendifar Andrew ◽

...

Keyword(s):

Multicenter Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Recombinant Human Hyaluronidase

Download Full-text

Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study

BMC Neurology ◽

10.1186/s12883-015-0491-1 ◽

2015 ◽

Vol 15 (1) ◽

Cited By ~ 7

Author(s):

Constant V. M. Verschuur ◽

S. R. Suwijn ◽

B. Post ◽

M. Dijkgraaf ◽

B. R. Bloem ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Double Blind ◽

Double Blind Placebo ◽

Early Parkinson’S Disease

Download Full-text

Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyy129 ◽

2018 ◽

Vol 48 (11) ◽

pp. 1012-1021 ◽

Cited By ~ 8

Author(s):

Satoshi Fukasawa ◽

Hiroyoshi Suzuki ◽

Kazushiro Kawaguchi ◽

Hidehisa Noguchi ◽

Kentaro Enjo ◽

...

Keyword(s):

Prostate Cancer ◽

Subgroup Analysis ◽

Japanese Patients ◽

Abiraterone Acetate ◽

Newly Diagnosed ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text